Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
PLoS One ; 16(10): e0259318, 2021.
Article in English | MEDLINE | ID: covidwho-1496537

ABSTRACT

PURPOSE: The purpose of this study was to characterize the nasopharyngeal microbiota of infants with possible and confirmed pertussis compared to healthy controls. METHODS: This prospective study included all infants <1 year with microbiologically confirmed diagnosis of pertussis attended at a University Hospital over a 12-month period. For each confirmed case, up to 2 consecutive patients within the same age range and meeting the clinical case definition of pertussis but testing PCR-negative were included as possible cases. A third group of asymptomatic infants (healthy controls) were also included. Nasopharyngeal microbiota was characterized by sequencing the V3-V4 region of the 16S rRNA gene. Common respiratory DNA/RNA viral co-infection was tested by multiplex PCR. RESULTS: Twelve confirmed cases, 21 possible cases and 9 healthy controls were included. Confirmed whooping cough was primarily driven by detection of Bordetella with no other major changes on nasopharyngeal microbiota. Possible cases had limited abundance or absence of Bordetella and a distinctive microbiota with lower bacterial richness and diversity and higher rates of viral co-infection than both confirmed cases and healthy controls. Bordetella reads determined by 16S rRNA gene sequencing were found in all 12 confirmed cases (100%), 3 out of the 21 possible cases (14.3%) but in any healthy control. CONCLUSION: This study supports the usefulness of 16S rRNA gene sequencing for improved sensitivity on pertussis diagnosis compared to real-time PCR and to understand other microbial changes occurring in the nasopharynx in children <1 year old with suspected whooping cough compared to healthy controls.


Subject(s)
Microbiota , Whooping Cough/microbiology , Bordetella/genetics , Bordetella/isolation & purification , Bordetella/pathogenicity , Case-Control Studies , Female , Humans , Infant , Male , Nasal Cavity/microbiology , Pharynx/microbiology , RNA, Ribosomal, 16S/genetics , Whooping Cough/diagnosis
2.
Emerg Infect Dis ; 27(11): 2904-2907, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1357505

ABSTRACT

Patients with severe acute respiratory syndrome coronavirus 2 infection may have bacterial co-infections, including pneumonia and bacteremia. Bordetella hinzii infections are rare, may be associated with exposure to poultry, and have been reported mostly among immunocompromised patients. We describe B. hinzii pneumonia and bacteremia in a severe acute respiratory syndrome coronavirus 2 patient.


Subject(s)
Bacteremia , Bordetella Infections/complications , Bordetella , COVID-19 , Bacteremia/complications , Bacteremia/diagnosis , Bordetella/genetics , Bordetella Infections/diagnosis , COVID-19/complications , Humans
SELECTION OF CITATIONS
SEARCH DETAIL